Claudine Navarro

794 total citations
11 papers, 639 citations indexed

About

Claudine Navarro is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Claudine Navarro has authored 11 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Claudine Navarro's work include Genetic factors in colorectal cancer (5 papers), Cancer-related Molecular Pathways (4 papers) and Cancer Research and Treatments (2 papers). Claudine Navarro is often cited by papers focused on Genetic factors in colorectal cancer (5 papers), Cancer-related Molecular Pathways (4 papers) and Cancer Research and Treatments (2 papers). Claudine Navarro collaborates with scholars based in France, India and Türkiye. Claudine Navarro's co-authors include Alain Puisieux, Qing Wang, Françoise Desseigne, Jean‐Christophe Saurin, C. Bergeron, Didier Frappaz, Christine Lasset, Thierry Lorca, Florence Couzon and Caroline Moyret‐Lalle and has published in prestigious journals such as Oncogene, International Journal of Cancer and Breast Cancer Research and Treatment.

In The Last Decade

Claudine Navarro

11 papers receiving 624 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudine Navarro France 10 381 319 252 230 83 11 639
Jen‐Lan Tsao United States 13 491 1.3× 457 1.4× 272 1.1× 345 1.5× 150 1.8× 14 834
Verónica Fernández Spain 11 270 0.7× 314 1.0× 232 0.9× 113 0.5× 59 0.7× 17 619
Carolina Sánchez‐Estévez Spain 10 125 0.3× 361 1.1× 202 0.8× 132 0.6× 72 0.9× 11 661
Paola Alberici Netherlands 10 287 0.8× 356 1.1× 431 1.7× 159 0.7× 60 0.7× 11 747
Steve Baylin United States 4 117 0.3× 341 1.1× 148 0.6× 156 0.7× 46 0.6× 4 499
Allan Balmain United Kingdom 9 98 0.3× 494 1.5× 304 1.2× 166 0.7× 95 1.1× 10 696
Azat Garipov United States 6 168 0.4× 679 2.1× 182 0.7× 204 0.9× 42 0.5× 6 837
R.S. Cornelis Netherlands 6 276 0.7× 258 0.8× 189 0.8× 212 0.9× 101 1.2× 6 489
Octavio A. Romero Spain 12 230 0.6× 575 1.8× 208 0.8× 125 0.5× 32 0.4× 15 721
Sangok Kim South Korea 9 175 0.5× 390 1.2× 153 0.6× 211 0.9× 21 0.3× 15 652

Countries citing papers authored by Claudine Navarro

Since Specialization
Citations

This map shows the geographic impact of Claudine Navarro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudine Navarro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudine Navarro more than expected).

Fields of papers citing papers by Claudine Navarro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudine Navarro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudine Navarro. The network helps show where Claudine Navarro may publish in the future.

Co-authorship network of co-authors of Claudine Navarro

This figure shows the co-authorship network connecting the top 25 collaborators of Claudine Navarro. A scholar is included among the top collaborators of Claudine Navarro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudine Navarro. Claudine Navarro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Boyault, Sandrine, Youenn Drouet, Claudine Navarro, et al.. (2011). Mutational characterization of individual breast tumors: TP53 and PI3K pathway genes are frequently and distinctively mutated in different subtypes. Breast Cancer Research and Treatment. 132(1). 29–39. 65 indexed citations
2.
Leroux, Dominique, Françoise Desseigne, Christine Lasset, et al.. (2007). Novel biallelic mutations inMSH6 andPMS2 genes: gene conversion as a likely cause ofPMS2 gene inactivation. Human Mutation. 28(11). 1084–1090. 51 indexed citations
3.
Navarro, Claudine, Eric Ruano, Françoise Desseigne, et al.. (2006). Systematic mRNA analysis for the effect ofMLH1 andMSH2 missense and silent mutations on aberrant splicing. Human Mutation. 27(2). 145–154. 68 indexed citations
4.
Wang, Qing, et al.. (2003). Chfr inactivation is not associated to chromosomal instability in colon cancers. Oncogene. 22(55). 8956–8960. 30 indexed citations
5.
Wang, Qing, Caroline Moyret‐Lalle, Florence Couzon, et al.. (2003). Alterations of anaphase-promoting complex genes in human colon cancer cells. Oncogene. 22(10). 1486–1490. 89 indexed citations
7.
Wang, Qing, Françoise Desseigne, Didier Frappaz, et al.. (1999). Neurofibromatosis and early onset of cancers in hMLH1-deficient children.. PubMed. 59(2). 294–7. 183 indexed citations
8.
Wang, Qing, Françoise Desseigne, Christine Lasset, et al.. (1997). GermlinehMSH2andhMLH1 gene mutations in incomplete HNPCC families. International Journal of Cancer. 73(6). 831–836. 19 indexed citations
9.
Thomasset, Nicole, et al.. (1993). Selective cytotoxicity of L-glutamic acid gamma-monohydroxamate (GAH) for melanoma tumor cells.. PubMed. 13(5A). 1393–8. 1 indexed citations
10.
Thomasset, Nicole, Roselyne Tournaire, Claudine Navarro, et al.. (1991). Anti‐tumoral activity of L and D isomers of aspartic acid β‐hydroxamate on L5178Y leukemia. International Journal of Cancer. 49(3). 421–424. 16 indexed citations
11.
Vila, Jorge, Nicole Thomasset, Claudine Navarro, & Jean‐François Doré. (1990). In vitro and in vivo anti‐tumor activity of L‐glutamic acid γ‐monohydroxamate against L1210 leukemia and B16 melanoma. International Journal of Cancer. 45(4). 737–743. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026